Novartis grabs blockbuster cancer nod for Piqray on double good news day 0 28.05.2019 16:34 Fiercepharma.com Novartis’ promise of 25 potential blockbuster launches is steadily coming to fruition. On the same day the FDA approved gene therapy Zolgensma, the U.S. regulator also waved through breast cancer drug Piqray. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
